Discovery May Lead to Improvements in Treating Alzheimer's Disease
the Psychiatry Advisor take:
A new drug target to fight Alzheimer's disease might also be used as a diagnostic tool for the disease, according to researchers at Pennsylvania State University.
A team found that the GABA neurotransmitter was drastically increased in the deformed versions of the normally large, star-shaped "astrocyte" cells which,support individual neurons in the brain. High concentrations of that neurotransmitter is a novel biomarker that researchers hope can be further investigated a a diagnosis tool and for treatment.
Research behind many drugs in development for Alzheimer's targets the sticky buildup of the amyloid protein known as plaques, which can cause neurons in the brain to die.
Japanese Drugmaker Accelerates Development of Alzheimer's Drug
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Triiodothyronine in the Treatment of Bipolar Depression
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
- E-Cigarettes Associated With More Harms Than Benefits at Population Level
- Examining Rates of Long-Term Opioid Use in Youth With Psychiatric Disorders
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Researchers Identify Novel Potential Biomarkers for Autism
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Supported Employment vs Transitional Work in Veterans With PTSD
- Comparing Pharmacologic Treatments for Prevention of Rehospitalization in BP
- Preliminary Evidence Suggests Suicidal Thinking Is Self-Reinforcing
- Lower Fluoxetine Efficacy in Elderly Patients With Major Depressive Disorder
- Personal Health Information Found in Recycling